Novartis, a global medicines company, and Aster DM Healthcare, one of the region’s largest healthcare providers, have signed an MoU in the areas of digital transformation and clinical research.
Aster, which has a large network of hospitals, clinics and pharmacies in seven countries, will have access to the advanced therapy platforms and data science of Novartis, a global leader investing in research and development.
“Data Analytics with focus on clinical research is one of the cornerstones of healthcare in future. Aster tries to stay ahead of the curve. We have associated with Novartis in the past and are glad to enter into a multi-faceted partnership to enhance Digital Transformation and Research,” said Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare.
read more : https://techxmedia.com/novartis-aster-sign-mou/